Back to Search
Start Over
Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARDrefractory rheumatoid arthritis.
- Source :
- RMD Open; 3/21/2017, Vol. 3 Issue 1, p1-10, 10p
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 20565933
- Volume :
- 3
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- RMD Open
- Publication Type :
- Academic Journal
- Accession number :
- 122028715
- Full Text :
- https://doi.org/10.1136/rmdopen-2016-000410